Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Nabriva Therapeutics plc | nbrv-20201231xex32d2.htm |
| EX-32.1 - EX-32.1 - Nabriva Therapeutics plc | nbrv-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Nabriva Therapeutics plc | nbrv-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Nabriva Therapeutics plc | nbrv-20201231xex31d1.htm |
| EX-23.1 - EX-23.1 - Nabriva Therapeutics plc | nbrv-20201231xex23d1.htm |
| EX-10.49 - EX-10.49 - Nabriva Therapeutics plc | nbrv-20201231xex10d49.htm |
| EX-10.48 - EX-10.48 - Nabriva Therapeutics plc | nbrv-20201231xex10d48.htm |
| EX-10.47 - EX-10.47 - Nabriva Therapeutics plc | nbrv-20201231xex10d47.htm |
| EX-10.46 - EX-10.46 - Nabriva Therapeutics plc | nbrv-20201231xex10d46.htm |
| EX-10.31 - EX-10.31 - Nabriva Therapeutics plc | nbrv-20201231xex10d31.htm |
| EX-10.18 - EX-10.18 - Nabriva Therapeutics plc | nbrv-20201231xex10d18.htm |
| EX-10.8 - EX-10.8 - Nabriva Therapeutics plc | nbrv-20201231xex10d8.htm |
| EX-4.1 - EX-4.1 - Nabriva Therapeutics plc | nbrv-20201231xex4d1.htm |
| 10-K - 10-K - Nabriva Therapeutics plc | nbrv-20201231x10k.htm |
Exhibit 21.1
SUBSIDIARIES OF NABRIVA THERAPEUTICS plc
Nabriva Therapeutics GmbH |
| Austria |
|
|
|
Nabriva Therapeutics Ireland Designated Activity Company |
| Ireland |
|
|
|
Zavante Therapeutics, Inc. |
| Delaware |
|
|
|
Nabriva Therapeutics US, Inc. |
| Delaware |